Compared to NAD precursors like NMN & NR, there’s almost nothing known about the effec

Partially SupportedThe efficacy of intravenous (IV) or sublingual (SL) NMN or NR compared to oral administration is a subject of interest and requires further consideration.

Partially SupportedA Pubmed search for 'nicotinamide mononucleotide human trial' yields 73 papers, while a search for 'NAD IV' yields zero.

Partially SupportedInjected NAD+ acts as an extracellular danger signal, potentially leading to autoimmunity and inflammation.

Partially SupportedLongevity is achieved by increasing NAD+ inside cells via efficient mitochondrial function, not through intravenous administration.

Compared to NAD precursors like NMN &amp; NR, there’s almost nothing known about the effec

Compared to NAD precursors like NMN & NR, there’s almost nothing known about the effec